Proteome Sciences plc
PRM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £2 | £3 | £2 | £2 |
| % Growth | -30.4% | 20.4% | 21.9% | – |
| Cost of Goods Sold | £2 | £3 | £2 | £2 |
| Gross Profit | -£0 | £0 | £1 | -£12,623 |
| % Margin | -4.8% | 2.2% | 27.6% | -694,329.5% |
| R&D Expenses | £0 | £0 | £0 | £1 |
| G&A Expenses | £0 | £0 | £1 | £1 |
| SG&A Expenses | £2 | £1 | £1 | £1 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | -£0 | £1 | £0 |
| Operating Expenses | £2 | £1 | £2 | £1 |
| Operating Income | -£2 | -£1 | -£2 | -£1 |
| % Margin | -87.3% | -24.2% | -77% | -80.2% |
| Other Income/Exp. Net | -£0 | -£0 | -£0 | -£0 |
| Pre-Tax Income | -£2 | -£1 | -£2 | -£2 |
| Tax Expense | £0 | £0 | £0 | -£0 |
| Net Income | -£2 | -£1 | -£2 | -£2 |
| % Margin | -115.2% | -44.7% | -99.8% | -102.6% |
| EPS | -0.007 | -0.004 | -0.008 | -0.006 |
| % Growth | -80% | 46.7% | -19% | – |
| EPS Diluted | -0.007 | -0.004 | -0.008 | -0.006 |
| Weighted Avg Shares Out | 295 | 298 | 295 | 295 |
| Weighted Avg Shares Out Dil | 295 | 298 | 295 | 295 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£1 | -£0 | -£1 | -£1 |
| % Margin | -65.1% | -9% | -57.6% | -69.4% |